| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B | $5.4B | $4.8B | $1.1B | $5.1B | $1.2B | $1.2B | $1.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | $0.2B | — | $0.2B | $0.1B | $0.1B |
| Net Income | $0.6B | $0.5B | $0.4B | $0.1B | $0.4B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $5.62 | $4.53 | $3.51 | $0.89 | $4.15 | $0.87 | $0.69 | $0.29 |
| EPS (Diluted) | $5.54 | $4.46 | $3.47 | $0.89 | $4.11 | $0.86 | $0.68 | $0.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.1B | $6.5B | $6.1B | $5.6B | $6.9B | $6.4B | $6.1B | $5.2B |
| Current Assets | $0.9B | $0.9B | $0.8B | $0.7B | $0.9B | $0.9B | $0.8B | $0.7B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.2B | $0.1B | $0.1B |
| Total Liabilities | $3.8B | $3.7B | $3.8B | $3.8B | $4.5B | $4.4B | $4.1B | $3.4B |
| Current Liabilities | $0.8B | $0.8B | $0.7B | $0.6B | $0.7B | $0.7B | $0.7B | $0.7B |
| Stockholders' Equity | $2.4B | $2.1B | $1.6B | $1.3B | $1.9B | $1.6B | $1.4B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | $0.7B | $0.7B | $0.7B | $0.6B | $0.8B |
| Investing Cash Flow | $-0.8B | $-0.7B | $-0.6B | $-0.6B | $-0.7B | $-0.4B | $-0.7B | $-0.4B |
| Capital Expenditures | — | — | — | $0.6B | $0.5B | $0.4B | $0.4B | $0.3B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.2B | $-0.1B | $-0.2B | $-0.1B | $0.0B | $-0.3B |